Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. Journal of oncology [J Oncol] Journal article | | Title | Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry. | | Author(s) | Martin RC, Joshi J, Robbins K, Tomalty D, O'Hara R, Tatum C | | Institution | Division of Surgical Oncology, University of Louisville School of Medicine, 315 East Broadway-Rm 311, Louisville, KY 40292, USA. | | Source | J Oncol 2009.:539795. | | Abstract | The purpose of this study was to evaluate the patient tolerance and efficacy of delivering locoregional chemotherapy to metastatic colorectal (MC) hepatic metastases via hepatic trans-arterial approach using irinotecan loaded drug eluting beads. This open-label, multi-center, single arm study included 30 MC patients, who had failed first line therapy. Of the 57 total embolization sessions, 12 (21% of sessions) were associated with adverse reactions during or after the treatment. After a median followup of 9 months, response rates by modified RECIST were 75% at 3 months and 66% at 6 months. Hepatic trans-arterial therapy using Irinotecan loaded DC Bead(TM) was safe and effective in the treatment of MCC as demonstrated by a minimal complication rate and acceptable tumor response. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19888427 |
|
|
| |
Advertise on this site.
| | |
|
